These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17430161)

  • 1. Stabilizing the vulnerable plaque: the search for the magic bullet.
    Pasterkamp G; Daemen M
    Curr Pharm Des; 2007; 13(10):979-82. PubMed ID: 17430161
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions.
    Raggi P; Genest J; Giles JT; Rayner KJ; Dwivedi G; Beanlands RS; Gupta M
    Atherosclerosis; 2018 Sep; 276():98-108. PubMed ID: 30055326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting inflammation in cardiovascular diseases. still a neglected field?
    Gómez-Guerrero C; Mallavia B; Egido J
    Cardiovasc Ther; 2012 Aug; 30(4):e189-97. PubMed ID: 21884009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial: Treatment of atherosclerosis as an inflammatory disease.
    Tuttolomondo A
    Curr Pharm Des; 2012; 18(28):4265. PubMed ID: 22857131
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-inflammatory therapeutics for the treatment of atherosclerosis.
    Charo IF; Taub R
    Nat Rev Drug Discov; 2011 May; 10(5):365-76. PubMed ID: 21532566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokines and atherosclerotic plaque progression: towards therapeutic targeting?
    Kraaijeveld AO; de Jager SC; van Berkel TJ; Biessen EA; Jukema JW
    Curr Pharm Des; 2007; 13(10):1039-52. PubMed ID: 17430167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmunity and autoinflammation: cardiovascular drug targets and design.
    Gasparyan AY
    Curr Pharm Des; 2014; 20(4):483-5. PubMed ID: 23565640
    [No Abstract]   [Full Text] [Related]  

  • 8. Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.
    Bertrand MJ; Tardif JC
    Expert Opin Emerg Drugs; 2017 Mar; 22(1):1-26. PubMed ID: 27927063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherosclerosis revisited from a clinical perspective: still an inflammatory disease?
    Santovito D; Weber C
    Thromb Haemost; 2017 Jan; 117(2):231-237. PubMed ID: 27975102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research Progress of Mechanisms and Drug Therapy For Atherosclerosis on Toll-Like Receptor Pathway.
    Yin QY; Zhao B; Qiu YY; Fei YX; Hu YH; Li YM
    J Cardiovasc Pharmacol; 2019 Nov; 74(5):379-388. PubMed ID: 31730559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenge of traditional Chinese medicines for allopathic practitioners.
    Karalliedde LD; Kappagoda CT
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H1967-9. PubMed ID: 19855052
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiatherogenic effects of vitamin E: the search for the Holy Grail.
    Kirmizis D; Chatzidimitriou D
    Vasc Health Risk Manag; 2009; 5():767-74. PubMed ID: 19774218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory drugs and atherosclerosis.
    Moubayed SP; Heinonen TM; Tardif JC
    Curr Opin Lipidol; 2007 Dec; 18(6):638-44. PubMed ID: 17993809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Exploration and consideration on effect of anti-inflammation and vulnerable plaque stabilization with Chinese medicines for promoting blood-circulation and detoxication].
    Xu H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 May; 28(5):393-4. PubMed ID: 18672761
    [No Abstract]   [Full Text] [Related]  

  • 15. Basic science review: Statin therapy--Part I: The pleiotropic effects of statins in cardiovascular disease.
    Sadowitz B; Maier KG; Gahtan V
    Vasc Endovascular Surg; 2010 May; 44(4):241-51. PubMed ID: 20403949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the prevention of plaque rupture as a new strategy for prevention of acute arterial cardiovascular events.
    Levi M; Stroes E
    Cardiovasc Res; 2008 Jun; 78(3):407-8. PubMed ID: 18413321
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease.
    Maranhão RC; Leite AC
    Curr Pharm Des; 2015; 21(9):1196-204. PubMed ID: 25312729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plaque biology: interesting science or pharmacological treasure trove?
    Loftus I; Thompson M
    Eur J Vasc Endovasc Surg; 2008 Nov; 36(5):507-16. PubMed ID: 18625571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia.
    Spartalis M; Spartalis E; Tzatzaki E; Tsilimigras DI; Moris D; Kontogiannis C; Kaminiotis VV; Paschou SA; Chatzidou S; Siasos G; Voudris V; Iliopoulos DC
    Cardiovasc Hematol Agents Med Chem; 2018; 16(2):74-80. PubMed ID: 30526472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inflammation and atherosclerosis – last piece of the puzzle has fallen into place].
    Jonasson L; Hansson G
    Lakartidningen; 2017 Oct; 114():. PubMed ID: 29292899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.